We are live on ! Find out more
TCON

TRACON Pharmaceuticals, Inc. Common Stock

Delisted

TCON was delisted on the 27th of June, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
OM
1
Opaleye Management
Massachusetts
$6.84M +$605K +20,000 +10%
IC
2
Ikarian Capital
Texas
$4.12M
Vanguard Group
3
Vanguard Group
Pennsylvania
$881K +$514 +17 +0.1%
LA
4
Linden Advisors
New York
$678K
BlackRock
5
BlackRock
New York
$459K +$5.87K +194 +1%
BFM
6
Boothbay Fund Management
New York
$386K
Geode Capital Management
7
Geode Capital Management
Massachusetts
$232K -$514 -17 -0.2%
Renaissance Technologies
8
Renaissance Technologies
New York
$201K +$102K +3,357 +99%
TI
9
Telemetry Investments
New York
$145K
JJ
10
Johnson & Johnson
New Jersey
$125K
State Street
11
State Street
Massachusetts
$112K
Bank of New York Mellon
12
Bank of New York Mellon
New York
$99.2K -$665 -22 -0.7%
Corient Private Wealth
13
Corient Private Wealth
Florida
$85.6K +$86.9K +2,873 New
Two Sigma Advisers
14
Two Sigma Advisers
New York
$79.3K -$71.8K -2,375 -47%
VF
15
Virtu Financial
New York
$67K +$68.5K +2,264 New
XSC
16
X-Square Capital
Puerto Rico
$27K
Northern Trust
17
Northern Trust
Illinois
$25.8K
H
18
HoyleCohen
California
$19.4K
MOS
19
MGO One Seven
Ohio
$17.6K
CBA
20
Coastal Bridge Advisors
Connecticut
$14.9K +$15.1K +500 New
TRCT
21
Tower Research Capital (TRC)
New York
$13K +$2.54K +84 +25%
ASN
22
Advisory Services Network
Georgia
$2.98K +$3.02K +100 New
Citadel Advisors
23
Citadel Advisors
Florida
$2.37K -$29.1K -961 -92%
UBS Group
24
UBS Group
Switzerland
$1.11K -$212 -7 -16%
CG
25
Cutler Group
California
$1K